ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043747 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Aggeliki K Meligova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Estrogen Receptor beta. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Secretariat for Research and Technology, Greece and the European Union (European Social Fund—ESF).
Abstract (Originalsprache)
Adjuvant endocrine therapy (AET) is the treatment of choice for early-stage estrogen receptor alpha (ERα)-positive breast cancer (BC). However, almost 40% of tamoxifen-treated cases display no response or a partial response to AET, thus increasing the need for new treatment options and strong predictors of the therapeutic response of patients at high risk of relapse. In addition to ERα, BC research has focused on ERβ1 and ERβ2 (isoforms of ERβ), the second ER isotype. At present, the impact of ERβ isoforms on ERα-positive BC prognosis and treatment remains elusive. In the present study, we established clones of MCF7 cells constitutively expressing human ERβ1 or ERβ2 and investigated their role in the response of MCF7 cells to antiestrogens [4-hydroxytamoxifen (OHΤ) and fulvestrant (ICI182,780)] and retinoids [all-trans retinoic acid (ATRA)]. We show that, compared to MCF7 cells, MCF7-ERβ1 and MCF7-ERβ2 cells were sensitized and desensitized, respectively, to the antiproliferative effect of the antiestrogens, ATRA and their combination and to the cytocidal effect of the combination of OHT and ATRA. Analysis of the global transcriptional changes upon OHT–ATRA combinatorial treatment revealed uniquely regulated genes associated with anticancer effects in MCF7-ERβ1 cells and cancer-promoting effects in MCF7-ERβ2 cells. Our data are favorable to ERβ1 being a marker of responsiveness and ERβ2 being a marker of resistance of MCF7 cells to antiestrogens alone and in combination with ATRA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.
- Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
- e-NIOS Applications PC, 25 Alexandros Pantou str., 17671 Kallithea, Greece.
ORCID-Profile: Aristotelis Chatziioannou, Olga Papadodima, Eleftherios Pilalis, Michael N Alexis, Dimitra J Mitsiou
Förderung
- General Secretariat for Research and Technology
- Greece and the European Union (European Social Fund—ESF)
Zitieren
APA
Meligova, A. K., Siakouli, D., Stasinopoulou, S., Xenopoulou, D. S., Zoumpouli, M., Ganou, V., Gkotsi, E. F., Chatziioannou, A., Papadodima, O., Pilalis, E., Alexis, M. N., & Mitsiou, D. J. (2023). ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043747
Vancouver
Meligova AK, Siakouli D, Stasinopoulou S, Xenopoulou DS, Zoumpouli M, Ganou V, et al. ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043747
BibTeX
@article{Meligova2023,
author = {Meligova, Aggeliki K and Siakouli, Dimitra and Stasinopoulou, Sotiria and Xenopoulou, Despoina S and Zoumpouli, Maria and Ganou, Vassiliki and Gkotsi, Eleni-Fani and Chatziioannou, Aristotelis and Papadodima, Olga and Pilalis, Eleftherios and Alexis, Michael N and Mitsiou, Dimitra J},
title = {ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043747}
}
EUVIMED